The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
They put out the RNS as the trading update was due. There’s no strategy there.
NCYT set some expectations for the market in terms of timelines and we are slightly behind on those. I think this also influenced DB’s confidence of sales in June.
We will get approvals at some point and I am sure there will be decent sales. When that happens then I would expect to be in profit again!
Samolly
Yes, adapt to a far larger market now.
Four times the number of daily new cases now than in February for NCYT.
The Company also needed to launch the software ....everyone seems to forget that.
Do any of you understand the complexities of getting this to market? I for one have topped up----have no doubt what so ever that this is a great Company going to make a difference to fighting the pandemic along with their other rage of products and test kits...
Samolly2- I'm assuming you are aware that this could completely change next week? Why do you think they have chosen to put an RNS out at this time...
Approvals are notoriously tied up in red tape in all countries. GDR are perfectly placed 8M in the bank for production, nobody seems to appreciate that that takes months too to set up even with Cytiva. Cytiva have GDR top of their list that they are working with...patience all!
Very similar to NCYT announcements at the start of their market penetration.
______
As of 27 February 2020, Primerdesign has sold over GBP0.93m (EUR1.1m) of CE-Mark and research use only (RUO) tests. Since launching its CE-Mark test, the Company is experiencing high levels of interest in its product. The value of quotations has grown significantly as Novacyt is currently involved in active discussions with representatives from a number of countries which have an acute need for tests as part of their national screening programmes. D ue to the high level of interest in the Primerdesign COVID-19 test and rapidly evolving nature of this outbreak, the Company cannot predict with any certainty the conversion rate of these ongoing enquiries into orders.
The Company is working closely with the US Food and Drug Administration (FDA) to meet the stringent requirements for Emergency Use Approval (EUA) of its COVID-19 test and is hopeful its application will be successful. A number of other national health agencies continue to review Novacyt's test, but the Company is unable to indicate when these approvals might be granted. As soon as an approval is granted, the Company will communicate this.
Very similar to NCYT announcements at the start of their market penetration.
______
As of 27 February 2020, Primerdesign has sold over GBP0.93m (EUR1.1m) of CE-Mark and research use only (RUO) tests. Since launching its CE-Mark test, the Company is experiencing high levels of interest in its product. The value of quotations has grown significantly as Novacyt is currently involved in active discussions with representatives from a number of countries which have an acute need for tests as part of their national screening programmes. D ue to the high level of interest in the Primerdesign COVID-19 test and rapidly evolving nature of this outbreak, the Company cannot predict with any certainty the conversion rate of these ongoing enquiries into orders.
The Company is working closely with the US Food and Drug Administration (FDA) to meet the stringent requirements for Emergency Use Approval (EUA) of its COVID-19 test and is hopeful its application will be successful. A number of other national health agencies continue to review Novacyt's test, but the Company is unable to indicate when these approvals might be granted. As soon as an approval is granted, the Company will communicate this.
Nicely said samolly
You think that an indicative order is the same as a sale.
lol
My only lack of understanding is why you're not in a straight jacket.
Go and try to talk down another stock somewhere else.
It's obvious you have no commercial experience.
Did you work for the council before retiring ?
Thank you RollingInit for displaying your lack of understanding so clearly to the board.
Mugsy
Not as 'special' as your needs.
An order is a sale, whether you like it or not.
Trot on.
Since you said FOMO kicking in, it dropped further. Are you trolling us ST?
LB28 so now you are claiming that although in the RNS they talk about indicative orders, that because they didn’t explicitly say no sales had been finalised that there still might have been finalised sales?
That’s special.
How can you agree LB28? You thought we had finalised sales?
They love dropping this!
That was a good update. Things are taking a little longer than expected but lots of great stuff in the pipeline
Rising back up now.. idiots.